A Review of Topical Corticosteroid Sprays for the Treatment of Inflammatory Dermatoses

Kyle A Habet MD [1], Sree S Kolli BA[1], Adrian Pona MD[1], Steven R Feldman MD, PhD [1,2,3] Affiliations: [1] Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina. [2] Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina, [3] Department of Social Sciences & Health Policy,…

Update on Hydroxychloroquine

Update on Hydroxychloroquine.

The latest study finds no benefit from hydroxychloroquine. Hydroxycholorquine was heralded as a potential game-changer for treating COVID-19. However, a new study shows that the drug is of little benefit.[1] This does not mean it should be written off as a potential treatment option. It has shown antiviral activity in-vitro and the rationale for its use is plausible. More evidence is still needed and clinical trials are still ongoing.

A Review of Topical Corticosteroid Foams

Jessica Payne BS, Kyle A. Habet MD, Adrian Pona MD, Steven R. Feldman MD PhD
Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC
Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC
Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC